Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
CEPH > SEC Filings for CEPH > Form 8-K on 22-Jun-2009All Recent SEC Filings

Show all filings for CEPHALON INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for CEPHALON INC

22-Jun-2009

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On June 19, 2009, Cephalon, Inc. (the "Company") issued a press release announcing results from a pivotal clinical trial of lestaurtinib (CEP-701) in patients with relapsed acute myelogenous leukemia (AML) expressing FLT3 activating mutations. The Company hereby incorporates by reference the press release dated June 19, 2009, attached hereto as Exhibit 99.1, and made a part of this Item 8.01.



Item 9.01 Financial Statements and Exhibits. 

(d) Exhibits.

    Exhibit No.        Description of Document
    99.1          Press Release dated June 19, 2009

  Add CEPH to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CEPH - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.